Meeting Abstract
A pilot study of a novel anti-inflammatory and anti-fibrotic agent, pirfenidone, in patients with liver cirrhosis.
Fecha
2003Autor
Armendariz-Borunda, J
Islas-Carbajal, MC
Meza, E
Rincon, AR
Alvarez, A
Goodman, ZD
Sandoval, A
Covarrubias, A
Arechiga, G
García, L